Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125081413 | 12508141 | 3 | F | 2013 | 20160912 | 20160629 | 20160915 | PER | US-PFIZER INC-2016289008 | PFIZER | 65.00 | YR | M | Y | 49.44000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125081413 | 12508141 | 1 | PS | SKELAXIN | METAXALONE | 1 | Oral | 800 MG, 3X/DAY, LONG WHITE PILL | U | 114131 | 13217 | 800 | MG | TABLET | TID | ||||
| 125081413 | 12508141 | 2 | SS | SKELAXIN | METAXALONE | 1 | Oral | 800 MG, 2X/DAY | U | 13217 | 800 | MG | TABLET | BID | |||||
| 125081413 | 12508141 | 3 | C | ROPINIROLE. | ROPINIROLE | 1 | Oral | 2 MG, 3X/DAY, SMALL PILL | 0 | 2 | MG | TID | |||||||
| 125081413 | 12508141 | 4 | C | OXYGEN. | OXYGEN | 1 | UNK,(USE AS DIRECTED) | 0 | |||||||||||
| 125081413 | 12508141 | 5 | C | LATANOPROST. | LATANOPROST | 1 | 0.005 %, 1X/DAY,(IN STILL 1 DROP TO BOTH EYE AT BED TIME) | 0 | .005 | PCT | QD | ||||||||
| 125081413 | 12508141 | 6 | C | ANUSOL-HC | 2 | Topical | 2.5 %, 2X/DAY(EVERY DAY TO THE AFFECTED AREA(S)) | 0 | 2.5 | PCT | BID | ||||||||
| 125081413 | 12508141 | 7 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50MG/ACTUATION,1 SPRAY BY INTRANASAL ROUTE 2 TIME EVERY DAY IN EACH NOSTRIL | 0 | ||||||||||
| 125081413 | 12508141 | 8 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 625 MG, 2X/DAY,(3 TABLET) | 0 | 625 | MG | TABLET | BID | ||||||
| 125081413 | 12508141 | 9 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 50 MG,INHALE 2 SPRAY EVERY DAY IN EACH NOSTRIL. | 0 | ||||||||||
| 125081413 | 12508141 | 10 | C | LEVSIN | HYOSCYAMINE SULFATE | 1 | Oral | 0.125 MG, AS NEEDED (TAKE 1-2 TABLETS BY ORAL ROUTE EVERY 4-6 HOURS ) | 0 | .125 | MG | TABLET | |||||||
| 125081413 | 12508141 | 11 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 160MCG-4.5MCG/ACTUATION,INHALE 2 PUFF BY INHALATION ROUTE 2 TIME EVERY DAY IN THE MORNING AND EVENIN | 0 | |||||||||||
| 125081413 | 12508141 | 12 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 2X/DAY | 0 | 40 | MG | CAPSULE | BID | ||||||
| 125081413 | 12508141 | 13 | C | ANTIVERT | MECLIZINE HYDROCHLORIDE | 1 | Oral | 25 MG, (TAKE 1 TABLET EVERY 6 HOURS) | 0 | 25 | MG | TABLET | |||||||
| 125081413 | 12508141 | 14 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | 6MG/0.5 ML,(INJECT 0.5ML UNDER SKIN ONCE, MAY REPEAT ) | 0 | |||||||||||
| 125081413 | 12508141 | 15 | C | SUCCINATE SODIUM | 2 | UNK, (1 HOUR AFTER THE FIRST DOSE IF HEADACHE RETURNS. MAX 2 DOSES IN 24 HOURS) | 0 | ||||||||||||
| 125081413 | 12508141 | 16 | C | FLOVENT HFA | FLUTICASONE PROPIONATE | 1 | Nasal | 220 UG, 2X/DAY | 0 | 220 | UG | BID | |||||||
| 125081413 | 12508141 | 17 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Oral | 90 UG, AS NEEDED,(ONE INHALATION FOUR TIME PER DAY AS NEEDED.) | 0 | 90 | UG | ||||||||
| 125081413 | 12508141 | 18 | C | Ipratropium albuterol | ALBUTEROLIPRATROPIUM | 1 | 0.5 MG-3 MG (2.5 MG BASE)/3ML, USE 1 VIAL IN NEBULIZER 3 TO 4 TIMES DAILY | 0 | |||||||||||
| 125081413 | 12508141 | 19 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Subcutaneous | 6 MG, MAY BE REPEATED 1 HOUR AFTER THE FIRST DO) | 0 | 6 | MG | ||||||||
| 125081413 | 12508141 | 20 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 125081413 | 12508141 | 21 | C | DONNATAL | ATROPINE SULFATEHYOSCYAMINE SULFATEPHENOBARBITALSCOPOLAMINE HYDROBROMIDE | 1 | Oral | 16.2MG-0.1037MG-0.0194 MG-0.0065MG, AS NEEDED,3 TIMES A DAY | 0 | TABLET | |||||||||
| 125081413 | 12508141 | 22 | C | ROPINIROLE HCL | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 2 MG, 3X/DAY | 0 | 2 | MG | TABLET | TID | ||||||
| 125081413 | 12508141 | 23 | C | ROPINIROLE HCL | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 1 MG, 3X/DAY | 0 | 1 | MG | TABLET | TID | ||||||
| 125081413 | 12508141 | 24 | C | TIZANIDINE HCL | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 4 MG, AS NEEDED, EVERY 8 HOURS AS NEEDED NOT TO EXCEED 3 DOSE IN 24 HOUR | 0 | 4 | MG | TABLET | |||||||
| 125081413 | 12508141 | 25 | C | CHERATUSSIN AC | CODEINE PHOSPHATEGUAIFENESIN | 1 | Oral | 5 ML, 1X/DAY | 0 | 5 | ML | QD | |||||||
| 125081413 | 12508141 | 26 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 45 MG, 1X/DAY | 0 | 45 | MG | TABLET | QD | ||||||
| 125081413 | 12508141 | 27 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 125081413 | 12508141 | 28 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 80 MG, 1X/DAY | 0 | 80 | MG | TABLET | QD | ||||||
| 125081413 | 12508141 | 29 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 0 | 300 | MG | CAPSULE | TID | ||||||
| 125081413 | 12508141 | 30 | C | BUTALBITAL-ACETAMINOPHEN-CAFFEINE | 2 | Oral | 50MG-325MG-40MG, ( THREE TIMES DAILY AS NEEDED.) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125081413 | 12508141 | 1 | Myalgia |
| 125081413 | 12508141 | 3 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125081413 | 12508141 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125081413 | 12508141 | 1 | 20160121 | 0 | ||
| 125081413 | 12508141 | 3 | 2015 | 0 |